Get the Stockscreener App
17.10
1.04%
-0.18
After Hours:
17.12
0.02
+0.12%
Overview
News
Price History
Option Chain
Financials
Why KVUE Down?
Discussions
Forecast
Dividend History
Kenvue Inc stock is traded at $17.10, with a volume of 51.30M.
It is down -1.04% in the last 24 hours and up +5.36% over the past month.
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
See More
Previous Close:
$17.28
Open:
$17.28
24h Volume:
51.30M
Relative Volume:
1.24
Market Cap:
$32.76B
Revenue:
$15.14B
Net Income/Loss:
$1.42B
P/E Ratio:
23.23
EPS:
0.7361
Net Cash Flow:
$1.63B
1W Performance:
-1.27%
1M Performance:
+5.36%
6M Performance:
-19.94%
1Y Performance:
-20.50%
1-Day Range:
$17.07
$17.40
1-Week Range:
$17.07
$17.49
52-Week Range:
$14.02
$25.17
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue Inc
Sector
Industry
Phone
908-874-1200
Address
1 KENVUE WAY, SUMMIT
Compare KVUE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
17.10 | 33.11B | 15.14B | 1.42B | 1.63B | 0.7361 |
|
PG
Procter Gamble Co
|
145.52 | 345.39B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
65.20 | 142.99B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
77.73 | 64.27B | 20.10B | 3.04B | 3.44B | 3.569 |
|
EL
Estee Lauder Cos Inc
|
107.94 | 37.95B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KMB
Kimberly Clark Corp
|
101.51 | 34.17B | 18.08B | 1.81B | 1.67B | 5.904 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-29-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-26-25 | Upgrade | Rothschild & Co Redburn | Neutral → Buy |
| Apr-10-25 | Initiated | Redburn Atlantic | Neutral |
| Mar-24-25 | Initiated | Evercore ISI | In-line |
| Jan-06-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-12-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Sep-24-24 | Initiated | Jefferies | Buy |
| Sep-24-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-28-24 | Resumed | Citigroup | Neutral |
| Apr-11-24 | Initiated | Bernstein | Underperform |
| Apr-03-24 | Initiated | William Blair | Mkt Perform |
| Mar-01-24 | Resumed | Goldman | Neutral |
| Nov-17-23 | Initiated | Piper Sandler | Neutral |
| Sep-11-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-07-23 | Initiated | Canaccord Genuity | Buy |
| Sep-06-23 | Initiated | Argus | Hold |
| Aug-24-23 | Upgrade | Goldman | Neutral → Buy |
| Jul-25-23 | Initiated | Edward Jones | Buy |
| Jun-01-23 | Initiated | HSBC Securities | Hold |
| May-30-23 | Initiated | BofA Securities | Buy |
| May-30-23 | Initiated | Citigroup | Neutral |
| May-30-23 | Initiated | Deutsche Bank | Hold |
| May-30-23 | Initiated | Exane BNP Paribas | Neutral |
| May-30-23 | Initiated | Goldman | Neutral |
| May-30-23 | Initiated | JP Morgan | Overweight |
| May-30-23 | Initiated | RBC Capital Mkts | Outperform |
| May-30-23 | Initiated | UBS | Neutral |
View All
Kenvue Inc Stock (KVUE) Latest News
Will Kenvue Inc. stock deliver strong dividend growthJuly 2025 Price Swings & Verified Swing Trading Watchlists - Улправда
Rep. Gilbert Ray Cisneros, Jr. Buys Kenvue Inc. (NYSE:KVUE) Shares - MarketBeat
Share offerings prompt huge insider buying in these 3 biotechs - MSN
Assenagon Asset Management S.A. Has $116.31 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Faces FDA Petition to Remove Key Benadryl Ingredient - Bloomberg.com
Kenvue faces FDA petition to remove Benadryl's active ingredient- Bloomberg News - TradingView — Track All Markets
Should You Buy Kenvue Stock After Its 30% Plunge? - MSN
Kimberly-Clark to buy Kenvue (NYSE: KVUE) in $3.50 cash-plus-stock deal - Stock Titan
Orion Porfolio Solutions LLC Purchases 66,112 Shares of Kenvue Inc. $KVUE - MarketBeat
Massive Stock Purchase Signals Confidence in Kenvue’s Future! - TipRanks
How the Narrative Surrounding Kimberly-Clark Is Shifting After the Planned Kenvue Acquisition - Yahoo Finance
Insider Buying: Kenvue (NYSE:KVUE) Director Acquires 3,177,694 Shares of Stock - MarketBeat
Insider Buying: Kenvue (NYSE:KVUE) Director Buys 3,200,000 Shares of Stock - MarketBeat
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - MSN
Jacobs & Co. CA Boosts Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Stock (KVUE) Today: Latest News, Deal Outlook, Analyst Forecasts and Key Risks (Dec. 15, 2025) - ts2.tech
Troy Asset Management Ltd Lowers Position in Kenvue Inc. $KVUE - MarketBeat
Stance Capital LLC Acquires New Position in Kenvue Inc. $KVUE - MarketBeat
Cullen Capital Management LLC Sells 6,565,339 Shares of Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark's High-Stakes Bet Against The Significant Odds Of M&A (NASDAQ:KMB) - Seeking Alpha
Halper Sadeh LLC Encourages AVDL, CMA, KVUE Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.
Lazard Asset Management LLC Has $111.77 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Neuberger Berman Group LLC Increases Stake in Kenvue Inc. $KVUE - MarketBeat
Levels Update: Will Kenvue Inc stock attract ESG investorsWeekly Earnings Recap & Consistent Income Trade Ideas - moha.gov.vn
(KVUE) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Third Point LLC Has $178.43 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark: The Kenvue Deal Could Be Used To Cut The DividendStrong Sell - Seeking Alpha
The New York Stock Exchange | NYSE - NYSE
Kenvue Inc. $KVUE is Maverick Capital Ltd.'s 9th Largest Position - MarketBeat
Will Kenvue Inc stock pay special dividendsMarket Activity Summary & Daily Chart Pattern Signal Reports - moha.gov.vn
Kimberly-Clark Reaches For Kenvue: Life-Saving Hand Or Capitalizing On Weakness? (KVUE) - Seeking Alpha
Kenvue Inc. $KVUE Shares Sold by State Street Corp - MarketBeat
Natixis Buys 96,644 Shares of Kenvue Inc. $KVUE - MarketBeat
Bank of Nova Scotia Buys 460,562 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. (NYSE:KVUE) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
GS Equity Income Fund: Q3 2025 Witnesses Fundamental Strength And Expansive Margin Opportunities - Seeking Alpha
Kenvue Inc. Stock Rises Tuesday, Outperforms Market - 富途牛牛
Texas Attorney General Ken Paxton Secures TRO Against Johnson & - Hoodline
Kenvue in 2025: New office, top clinical studies and product breakthroughs - Kenvue
Texas Granted TRO Against Kenvue, Johnson & Johnson for Alleged Unregistered Foreign Company Status - thetexan.news
California Public Employees Retirement System Has $67.86 Million Position in Kenvue Inc. $KVUE - MarketBeat
Johnson & Johnson to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Investing News Network
Tylenol makers J&J, Kenvue not registered to operate in Texas, says AG Ken Paxton - KVUE
Paxton Secures Major Win Against Johnson & Johnson and Kenvue - Texas Border Business
Kenvue and J&J must register in Texas or face business ban, judge rules - Investing.com Nigeria
Kenvue and J&J must register in Texas or face business ban, judge rules By Investing.com - Investing.com South Africa
Texas AG Secures Restraining Order Against J&J, Kenvue Over Alleged Business Registration Violations - Dallas Express
Tylenol Maker Isn’t Registered to Operate in Texas, Judge Says - Bloomberg.com
P/E Ratio Insights for Kenvue - Benzinga
Kenvue Inc. $KVUE Position Raised by Ossiam - MarketBeat
Kenvue (KVUE): Assessing Valuation After Steady Earnings Growth and Weak One-Year Share Price Returns - Yahoo Finance
Kenvue Inc Stock (KVUE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
2.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):